Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study

BACKGROUND: Several studies have shown that heart rate control with selective beta-1 blockers in septic shock is safe. In these trials, esmolol was administered 24 h after onset of septic shock in patients who remained tachycardic. While an earlier use of beta-blockers might be beneficial, such use...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Bruno, Fritz, Caroline, Piona, Caroline, Duarte, Kevin, Morelli, Andrea, Guerci, Philippe, Kimmoun, Antoine, Girerd, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791811/
https://www.ncbi.nlm.nih.gov/pubmed/33413583
http://dx.doi.org/10.1186/s13054-020-03445-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791811/
https://www.ncbi.nlm.nih.gov/pubmed/33413583
http://dx.doi.org/10.1186/s13054-020-03445-w

Ejemplares similares